These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus. Dutton S; Fleming SB; Ueda N; Heath DD; Hibma MH; Mercer AA Parasite Immunol; 2012 Jun; 34(6):312-7. PubMed ID: 22404504 [TBL] [Abstract][Full Text] [Related]
6. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes. Woollard DJ; Gauci CG; Heath DD; Lightowlers MW Vaccine; 2000 Oct; 19(4-5):498-507. PubMed ID: 11027814 [TBL] [Abstract][Full Text] [Related]
7. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy. Scheerlinck JP; Casey G; McWaters P; Kelly J; Woollard D; Lightowlers MW; Tennent JM; Chaplin PJ Vaccine; 2001 Jul; 19(28-29):4053-60. PubMed ID: 11427282 [TBL] [Abstract][Full Text] [Related]
8. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere. Zhang W; Li J; You H; Zhang Z; Turson G; Loukas A; McManus DP Am J Trop Med Hyg; 2003 Jan; 68(1):40-3. PubMed ID: 12556145 [TBL] [Abstract][Full Text] [Related]
9. The EG95 antigen of Echinococcus spp. contains positively selected amino acids, which may influence host specificity and vaccine efficacy. Haag KL; Gottstein B; Ayala FJ PLoS One; 2009; 4(4):e5362. PubMed ID: 19401778 [TBL] [Abstract][Full Text] [Related]
10. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts. Lightowlers MW; Heath DD Parassitologia; 2004 Jun; 46(1-2):27-31. PubMed ID: 15305682 [TBL] [Abstract][Full Text] [Related]
11. Molecular cloning of a vaccine antigen against infection with the larval stage of Echinococcus multilocularis. Gauci C; Merli M; Muller V; Chow C; Yagi K; Mackenstedt U; Lightowlers MW Infect Immun; 2002 Jul; 70(7):3969-72. PubMed ID: 12065546 [TBL] [Abstract][Full Text] [Related]
12. Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact. Larrieu E; Mujica G; Gauci CG; Vizcaychipi K; Seleiman M; Herrero E; Labanchi JL; Araya D; Sepúlveda L; Grizmado C; Calabro A; Talmon G; Poggio TV; Crowley P; Cespedes G; Santillán G; García Cachau M; Lamberti R; Gino L; Donadeu M; Lightowlers MW PLoS Negl Trop Dis; 2015; 9(10):e0004134. PubMed ID: 26517877 [TBL] [Abstract][Full Text] [Related]
13. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Lightowlers MW; Jensen O; Fernandez E; Iriarte JA; Woollard DJ; Gauci CG; Jenkins DJ; Heath DD Int J Parasitol; 1999 Apr; 29(4):531-4. PubMed ID: 10428628 [TBL] [Abstract][Full Text] [Related]
14. Limitations of the Echinococcus granulosus genome sequence assemblies for analysis of the gene family encoding the EG95 vaccine antigen. Gauci CG; Alvarez Rojas CA; Chow C; Lightowlers MW Parasitology; 2018 May; 145(6):807-813. PubMed ID: 29173204 [TBL] [Abstract][Full Text] [Related]
15. Immunology and molecular biology of Echinococcus infections. Lightowlers MW Int J Parasitol; 1990 Jul; 20(4):471-8. PubMed ID: 2210940 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of the EG95 hydatid vaccine in a macropodid host, the tammar wallaby. Barnes TS; Hinds LA; Jenkins DJ; Coleman GT; Colebrook AL; Kyngdon CT; Gauci CG; Lightowlers MW Parasitology; 2009 Apr; 136(4):461-8. PubMed ID: 19195411 [TBL] [Abstract][Full Text] [Related]
17. Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14. Almeida MS; Torloni H; Lee-Ho P; Vilar MM; Thaumaturgo N; Simpson AJ; Tendler M Parasite Immunol; 2003 Mar; 25(3):135-7. PubMed ID: 12911521 [TBL] [Abstract][Full Text] [Related]
18. Hydatid disease: vaccinology and development of the EG95 recombinant vaccine. Gauci C; Heath D; Chow C; Lightowlers MW Expert Rev Vaccines; 2005 Feb; 4(1):103-12. PubMed ID: 15757477 [TBL] [Abstract][Full Text] [Related]